TWST

Twist Bioscience Corporation

151.94 USD

Last updated Oct 9, 04:27 UTC

Yesterday HIGH

$167.29

Yesterday LOW

$152.5

52w HIGH

$219.71

52w LOW

$23.3

EPS

-0.56

PE

-271.32

Next Earnings

Nov 13, 2026

Overview News Unusual Options Flow Insider Transactions Government Trades Fundamentals

Twist Bioscience Corporation stock is up 21.05% since 30 days ago. The next earnings date is Nov 13, 2026. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 8 October’s closed higher than September. In the last 10 Unusual Options Trades, there were 3 PUTs, 7 CALLs. 43% of analysts rate it a buy.

Options Flow Last 10
Date & Time	Expiration Date	Strike Price	Trade Type	Size	Open Interest

08 Oct 13:32	16 Oct, 2026	165.00	PUT	15	107
08 Oct 13:43	20 Nov, 2026	195.00	CALL	350	388
08 Oct 13:43	20 Nov, 2026	155.00	CALL	150	153
08 Oct 13:47	20 Nov, 2026	145.00	PUT	35	1031
08 Oct 13:47	20 Nov, 2026	145.00	PUT	17	1031
08 Oct 14:04	15 Jan, 2027	200.00	CALL	50	238
08 Oct 14:45	15 Jan, 2027	160.00	CALL	12	40
08 Oct 15:52	17 Dec, 2027	150.00	CALL	40	181
08 Oct 15:52	17 Dec, 2027	150.00	CALL	10	181
08 Oct 18:22	16 Oct, 2026	72.50	CALL	10	11

Advanced Data Unlock

Henry Khederian

Wed Aug 19, 2026

Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report

TWST shares surge after Anthropic names the company an independent evaluator in a new AI-driven protein design campaign. The bullish momentum overshadows a critical short report published on X by activist short-seller Scorpion Capital.
Benzinga Newsdesk

Wed Aug 19, 2026

Watching Twist Bioscience; Scorpion Capital Issues Report On Co, States They Hold A Short Position

https://x.com/ScorpionFund/status/2090160099520348644?s=20
Vandana Singh

Wed Aug 19, 2026

Twist Bioscience Stock Hits 52-Week High - Here's Why

Twist Bioscience (TWST) stock jumped 17% after Anthropic chose the firm to test AI-designed proteins. Get the full market update.
Benzinga Newsdesk

Wed Aug 19, 2026

Twist Bioscience shares are trading higher after Anthropic named the company as an independent evaluator in a protein design campaign using its Claude Opus 4.8 and Mythos Preview AI models.
Avi Kapoor

Wed Aug 19, 2026

Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
Benzinga Newsdesk

Wed Aug 5, 2026

Twist Bioscience shares are trading higher after Piper Sandler maintained its Overweight rating on the stock and raised its price target from $85 to $115.
Benzinga Newsdesk

Wed Aug 5, 2026

Piper Sandler Maintains Overweight on Twist Bioscience, Raises Price Target to $115

Piper Sandler analyst David Westenberg maintains Twist Bioscience (NASDAQ:TWST) with a Overweight and raises the price target from $85 to $115.
Benzinga Newsdesk

Wed Aug 5, 2026

Reported Earlier, Twist Bioscience Prices Upsized Public Offering Of 3,125,000 Common Shares At $96.00 Per Share To Fund R&D And Manufacturing Expansion
Benzinga Newsdesk

Tue Aug 4, 2026

Twist Bioscience Announces $250M Public Stock Offering
Benzinga Newsdesk

Tue Aug 4, 2026

Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115

Baird analyst Catherine Ramsey maintains Twist Bioscience (NASDAQ:TWST) with a Outperform and raises the price target from $113 to $115.

Jefferies

Thu Oct 8, 14:51

hold

initial
Guggenheim

Thu Oct 1, 15:47

buy

confirm
Leerink Partners

Tue Sep 29, 18:25

buy

confirm
BWS Financial

Fri Sep 18, 15:52

sell

confirm
Leerink Partners

Thu Sep 17, 16:39

buy

confirm
BWS Financial

Wed Sep 9, 23:34

sell

initial
UBS

Wed Sep 9, 15:25

hold

initial

Advanced Data Unlock

Emily M Leproust, Chief Executive Officer

Mon Oct 5, 2026

TWST Recent Insider Trades and Stock Chart

4,548 shares sold
Adam Laponis, Chief Financial Officer

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

8,057 shares sold
Paula Green, SVP Human Resources

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

10,088 shares sold
Patrick John Finn, President and COO

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

25,714 shares sold
Emily M Leproust, Chief Executive Officer

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

45,736 shares sold
Dennis Cho, See Remarks

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

9,514 shares sold
Robert F Werner, Chief Accounting Officer

Fri Oct 2, 2026

TWST Recent Insider Trades and Stock Chart

1,482 shares sold
Emily M Leproust, Chief Executive Officer

Thu Oct 1, 2026

TWST Recent Insider Trades and Stock Chart

655 shares sold
Emily M Leproust, Chief Executive Officer

Thu Sep 24, 2026

TWST Recent Insider Trades and Stock Chart

5,203 shares sold
Dennis Cho, See Remarks

Mon Sep 21, 2026

TWST Recent Insider Trades and Stock Chart

348 shares sold
Paula Green, SVP Human Resources

Mon Sep 21, 2026

TWST Recent Insider Trades and Stock Chart

294 shares sold
Emily M Leproust, Chief Executive Officer

Mon Sep 21, 2026

TWST Recent Insider Trades and Stock Chart

1,687 shares sold
Emily M Leproust, Chief Executive Officer

Thu Sep 17, 2026

TWST Recent Insider Trades and Stock Chart

356,546 shares sold
Dennis Cho, See Remarks

Tue Sep 8, 2026

TWST Recent Insider Trades and Stock Chart

412 shares sold
Paula Green, SVP Human Resources

Tue Sep 8, 2026

TWST Recent Insider Trades and Stock Chart

907 shares sold
Emily M Leproust, Chief Executive Officer

Tue Sep 8, 2026

TWST Recent Insider Trades and Stock Chart

2,302 shares sold
Robert F Werner, Chief Accounting Officer

Tue Sep 8, 2026

TWST Recent Insider Trades and Stock Chart

238 shares sold